Skip to content

Comparison Between Two Analgesic Methods for Pain Relief Following Surgical Abortion

Comparison Between Two Analgesic Methods for Pain Relief Following Surgical Abortion

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02025166
Enrollment
82
Registered
2013-12-31
Start date
2014-01-31
Completion date
2015-01-31
Last updated
2013-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Pain, abortion, paracetamol, lornoxicam

Brief summary

To compare between the efficacy of Paracetamol IV vs. Lornoxicam IV in pain relief following surgical abortion. The medication will be given at the time of the procedure. Following the abortion, pain level will be evaluated.

Detailed description

Patients with medical indication for surgical abortion during first trimester will be divided to two groups. The study groups, the surgeons and the nurses will be blinded to one of the treatment arms. Pain will be evaluated at fixed intervals following the abortion. Comparison in pain levels between the study groups will be analysed.

Interventions

DRUGParacetamol

Pain treatment with aniline analgesics (paracetamol) at the time of the procedure

Pain treatment with NSAID (lornoxicam) at the time of the procedure

Sponsors

Rambam Health Care Campus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Elective surgical abortion for first trimester pregnancy

Exclusion criteria

* Chronic pelvic pain * Fibromyalgia * Pelvic inflammatory disease * Chronic renal failure, liver disease, peptic ulcer * cervical stenosis

Design outcomes

Primary

MeasureTime frameDescription
PainTwo hoursPain level will be evaluated by VAS

Countries

Israel

Contacts

Primary ContactLior Lowenstein, MD, MS
l_lior@rambam.health.gov.il97248542653

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026